Results 111 to 120 of about 7,517 (258)

A splice site variant defining the novel RHD*01(487‐3G) allele in trans to RHD*DAR1.2

Transfusion, Volume 65, Issue 1, Page E4-E6, January 2025.
Augusto Cezar‐Schmidt, Jeffrey Jean, Patricia Lee, Sunitha Vege, Connie M Westhoff, Jay P Hudgins   +5 more
wiley   +1 more source

Persistent complete molecular remission after nilotinib and graft-versus-leukemia effect in an acute lymphoblastic leukemia patient with cytogenetic relapse after allogeneic stem cell transplantation

Experimental Hematology & Oncology, 2012
We report the successful treatment and sustained molecular remission using single agent nilotinib in a relapsed Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia patient after allogeneic hematopoietic stem cell transplantation. Compared
Farnsworth Paul, Ward David, Reddy Vijay
doaj   +1 more source

Lower incidence of chronic graft-versus-host disease after ruxolitinib plus extracorporeal photopheresis versus ruxolitinib alone in steroid-refractory acute graft-versus-host disease following allogeneic stem cell transplantation

Haematologica
We compared long-term outcomes in 78 patients with steroid-refractory acute graft-versushost disease (SR-aGVHD) treated at the University Medical Center Hamburg, Germany between December 2015 and August 2022 who received either ruxolitinib alone (Ruxo ...
Iryna Lastovytska, Silke Heidenreich, Evgeny Klyuchnikov, Christian Niederwieser, Nico Gagelmann, Johanna Richter, Radwan Massoud, Kristin Rathje, Tetiana Perekhrestenko, Gaby Zeck, Catherina Lück, Dietlinde Janson, Christine Wolschke, Francis Ayuk, Nicolaus Kröger   +14 more
doaj   +1 more source

8-Mop/uva Inhibits Maturation Of Extracorporeal Photochemotherapy (ecp) Generated Dendritic Cells [PDF]

, 2011
Extracorporeal photochemotherapy (ECP), a cellular therapy involving a light activated drug, is FDA approved for the treatment of Cutaneous T-cell lymphoma (CTCL) and used for reversal of Graft-versus-Host Disease (GHVD) and solid organ transplant ...
Baird, Abigail Hart
core   +1 more source

Photopheresis for the Prevention of Rejection in Cardiac Transplantation [PDF]

, 1998
Mark L. Barr, Bruno M. Meiser, Howard J. Eisen, Robert Roberts, Ugolino Livi, Roberto Dall’Amico, Richard Dorent, Joseph G. Rogers, Branislav Radovančević, David O. Taylor, Valluvan Jeevanandam, C C Marboe   +11 more
openalex   +1 more source

Compassionate use of ruxolitinib in acute and chronic graft versus host disease refractory both to corticosteroids and extracorporeal photopheresis

Experimental Hematology & Oncology, 2017
Background Ruxolitinib is a potent inhibitor of JAK1/2 with proven efficacy in myelofibrosis. In recent years, research in graft versus host disease (GVHD) has revealed the role of activation of JAK pathways in alloreactive lymphocytes. Some reports have
Mauricio Sarmiento Maldonado, Pablo Ramírez Villanueva, Pablo Bertín Cortes-Monroy, Veronica Jara Arias, Katherine Soto Donoso, Pablo Uribe Gonzalez, Mauricio Ocqueteau Tachini, Jose Antonio Perez-Simón   +7 more
doaj   +1 more source

Fotoaferesi extracorporea come terapia di prima linea nel trattamento della GVHD cronica dopo trapianto allogenico di cellule staminali [PDF]

, 2008
Introduzione. La malattia del trapianto verso l’ospite cronica (cGVHD) è la più importante complicanza dopo trapianto di cellule staminali emopoietiche.
Tendas, Andrea
core  

Photopheresis for Chronic Rejection of Lung Allografts [PDF]

, 1995
Bonnie Slovis, James E. Loyd, Lloyd E. King   +2 more
openalex   +1 more source

Modulation Of Immunity By The Immunologic Zipper: The Role Of Glucocorticoid-Induced Leucine Zipper In Extracoporeal Photochemotherapy [PDF]

, 2014
Extracorporeal photochemotherapy (ECP) is a cellular therapy that is FDA approved for the treatment of a variety of T cell mediated diseases, including cutaneous T cell lymphoma, graft-versus-host disease, and solid organ transplantation rejection.
Feng, Hao
core   +1 more source

Photopheresis and the Red Man Syndrome [PDF]

, 1995
Robert Knobler
openalex   +1 more source